trifluoromethylpyridine has been researched along with 1-(3-chlorophenyl)piperazine in 1 studies
*1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure [MeSH]
*1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure [MeSH]
Studies (trifluoromethylpyridine) | Trials (trifluoromethylpyridine) | Recent Studies (post-2010) (trifluoromethylpyridine) | Studies (1-(3-chlorophenyl)piperazine) | Trials (1-(3-chlorophenyl)piperazine) | Recent Studies (post-2010) (1-(3-chlorophenyl)piperazine) |
---|---|---|---|---|---|
13 | 0 | 7 | 833 | 142 | 87 |
Protein | Taxonomy | trifluoromethylpyridine (IC50) | 1-(3-chlorophenyl)piperazine (IC50) |
---|---|---|---|
Beta-1 adrenergic receptor | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guertin, PA; Landry, ES | 1 |
1 other study(ies) available for trifluoromethylpyridine and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
Differential effects of 5-HT1 and 5-HT2 receptor agonists on hindlimb movements in paraplegic mice.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Drug Interactions; Exercise Test; Hindlimb; Levodopa; Locomotion; Male; Mice; Movement; Paraplegia; Piperazines; Pyridines; Quipazine; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Spinal Cord Injuries | 2004 |